Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

109.98
-1.2800-1.15%
Post-market: 109.95-0.0300-0.03%19:28 EDT
Volume:8.15M
Turnover:898.78M
Market Cap:136.81B
PE:23.25
High:111.37
Open:110.51
Low:109.48
Close:111.26
Loading ...

Gilead Q1 Veklury Sales $302 Mln

THOMSON REUTERS
·
25 Apr

Gilead Outlook 2025 Adj EPS, Product Sales Remains Unchanged

THOMSON REUTERS
·
25 Apr

Gilead Q1 Product Sales USD 6,613 Million

THOMSON REUTERS
·
25 Apr

Gilead Sciences Announces First Quarter 2025 Financial Results

THOMSON REUTERS
·
25 Apr

Gilead Sciences Announces First Quarter 2025 Financial Results

Business Wire
·
25 Apr

BUZZ-PREVIEW: Gilead Sciences stock rises ahead of earnings

Reuters
·
25 Apr

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More

Zacks
·
24 Apr

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi

Zacks
·
23 Apr

Gilead Sciences (GILD) To Report Earnings Tomorrow: Here Is What To Expect

StockStory
·
23 Apr

Optimistic Adjustments and Operational Efficiency Drive Buy Rating for Gilead Sciences

TIPRANKS
·
23 Apr

Promising Commercial Potential for Gilead’s Trodelvy Following Successful ASCENT-04 Trial

TIPRANKS
·
23 Apr

Correction to Gilead Sciences Veklury Sales Guidance Headline on Feb. 11

Dow Jones
·
23 Apr

Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom -- Barrons.com

Dow Jones
·
22 Apr

Is Gilead Sciences (GILD) a Cheap NASDAQ Stock to Buy According to Hedge Funds?

Insider Monkey
·
22 Apr

Gilead Sciences Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
22 Apr

Gilead reports ASCENT-04/KEYNOTE-D19 study met primary endpoint

TIPRANKS
·
21 Apr

Gilead ASCENT-04 data a ‘welcome surprise,’ says Oppenheimer

TIPRANKS
·
21 Apr

Gilead Says Trodelvy-Keytruda Combination Improved Progression-Free Survival in Breast Cancer Study

MT Newswires Live
·
21 Apr

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks
·
21 Apr

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type

Reuters
·
21 Apr